leflunomide has been researched along with kaempferol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ding, H; Dong, H; Hou, Z; Luo, C; Min, W; Qi, L; Wang, L; Xie, S; Yang, P; Yuan, K; Zhang, F | 1 |
Astin, JW; Chien, A; Crosier, KE; Crosier, PS; Eng, TC; Flores, MV; Jamieson, SM; Misa, JP | 1 |
2 other study(ies) available for leflunomide and kaempferol
Article | Year |
---|---|
Computational discovery and biological evaluation of novel inhibitors targeting histone-lysine N-methyltransferase SET7.
Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Cell Survival; Computational Chemistry; Computer Simulation; Drug Discovery; Escherichia coli; Histone-Lysine N-Methyltransferase; Humans; Molecular Structure; Protein Binding; Protein Conformation; Structure-Activity Relationship | 2020 |
An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis.
Topics: Animals; Antineoplastic Agents; Cinnarizine; Endothelial Cells; Female; Flunarizine; Humans; Isoxazoles; Kaempferols; Leflunomide; Lymph Nodes; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Inbred C57BL; Neoplasms; Random Allocation; Receptor Protein-Tyrosine Kinases; Zebrafish | 2014 |